National Clinical Research Centre of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Ren Fail. 2023 Dec;45(1):2152692. doi: 10.1080/0886022X.2022.2152692.
Anemia is a common complication in patients with progressive chronic kidney disease. This cohort study evaluated the prevalence, clinical features and prognosis of membranous nephropathy (MN) with anemia.
We retrospectively analyzed a cohort of MN patients diagnosed using renal biopsy between February 2012 and February 2018. The clinical and pathological characteristics at baseline were recorded, and the outcomes (hemoglobin, proteinuria and renal function) during follow-ups were also evaluated. Univariate and multivariate logistic regression analyses were performed to identify the independent risk factors for anemia in MN patients. The MN patients were divided according to the therapeutic effect they experienced as follows: without-anemia, completely corrected anemia, standard anemia treatment and nonstandard anemia treatment groups. We compared the rate of complete remission of MN and renal end-point events among the four groups.
The median age of 483 patients was 42.43 (26.59, 50.20) years at the time of MN diagnosis. The prevalence of anemia at baseline was 23.81%, and the cumulative prevalence was 50.72%. There were 133 cases of mild anemia, 103 cases of moderate anemia and 9 cases of severe anemia; in addition, there were 228 cases of normocytic anemia and 17 cases of microcytic hypochromic anemia. Multivariate logistic regression indicated that acute renal tubule injury >5% (OR = 1.634, 95% CI 1.034, 2.581; = 0.035), total protein level (OR = 0.949, 95% CI 0.923, 0.975; < 0.001), cholesterol level (OR = 0.833, 95% CI 0.749, 0.926, = 0.001), hypokalemia (OR = 2.612, 95% CI 1.227, 5.560, = 0.013) and hypophosphatemia (OR = 2.653, 95% CI 1.303, 5.403, = 0.007) were independent risk factors for anemia in MN patients. The complete remission rate of MN patients without anemia was significantly higher than that of anemia patients who exhibited treatment failure. The incidence of renal endpoint events was different among the four groups.
The anemia experienced by MN patients is mainly mild and moderate, normocytic anemia. The pathological features of acute renal tubular injury and clinical nutritional status are independent risk factors for anemia. There were differences in renal prognosis among anemia patients with different treatment outcomes.
贫血是进展性慢性肾脏病患者的常见并发症。本队列研究评估了伴有贫血的膜性肾病(MN)的患病率、临床特征和预后。
我们回顾性分析了 2012 年 2 月至 2018 年 2 月间经肾活检诊断为 MN 的患者队列。记录基线时的临床和病理特征,并评估随访期间的结局(血红蛋白、蛋白尿和肾功能)。采用单因素和多因素 logistic 回归分析确定 MN 患者贫血的独立危险因素。根据治疗效果将 MN 患者分为无贫血组、完全纠正贫血组、标准贫血治疗组和非标准贫血治疗组。比较四组 MN 完全缓解率和肾脏终点事件发生率。
483 例患者的中位年龄为 42.43(26.59,50.20)岁。基线时贫血的患病率为 23.81%,累积患病率为 50.72%。其中轻度贫血 133 例,中度贫血 103 例,重度贫血 9 例;此外,正细胞性贫血 228 例,小细胞低色素性贫血 17 例。多因素 logistic 回归分析表明,急性肾小管损伤>5%(OR=1.634,95%CI 1.034,2.581; = 0.035)、总蛋白水平(OR=0.949,95%CI 0.923,0.975; < 0.001)、胆固醇水平(OR=0.833,95%CI 0.749,0.926, = 0.001)、低钾血症(OR=2.612,95%CI 1.227,5.560, = 0.013)和低磷血症(OR=2.653,95%CI 1.303,5.403, = 0.007)是 MN 患者贫血的独立危险因素。无贫血 MN 患者的完全缓解率明显高于治疗失败的贫血患者。四组之间肾脏终点事件的发生率不同。
MN 患者的贫血主要为轻中度、正细胞性贫血。急性肾小管损伤的病理特征和临床营养状况是贫血的独立危险因素。不同治疗结局的贫血患者的肾脏预后存在差异。